Cleared Traditional

NATtrol BD MAX Vaginal Panel External Controls (K201403) - FDA 510(k) Clearance

Class II Microbiology device cleared through predicate-based substantial equivalence - typically does not require clinical trials.

K201403 · Zeptometrix · Microbiology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Feb 2022
Decision
615d
Days
Class 2
Risk

K201403 is an FDA 510(k) clearance for the NATtrol BD MAX Vaginal Panel External Controls. Classified as Assayed External Control Material For Microbiology Nucleic Acid Amplification (nat) Assays (product code PMN), Class II - Special Controls.

Submitted by Zeptometrix (Buffalo, US). The FDA issued a Cleared decision on February 2, 2022 after a review of 615 days - an unusually long review period, suggesting complex equivalence evaluation.

This device falls under the Microbiology FDA review panel, regulated under 21 CFR 866.3920 - the FDA microbiology device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: High-complexity regulatory submission. Elevated predicate reliance profile. The extended review timeline suggests the FDA required additional documentation before confirming substantial equivalence - a pattern common in complex or first-of-kind Microbiology submissions.

View all Zeptometrix devices

Submission Details

510(k) Number K201403 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received May 28, 2020
Decision Date February 02, 2022
Days to Decision 615 days
Submission Type Traditional
Review Panel Microbiology (MI)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
513d slower than avg
Panel avg: 102d · This submission: 615d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code PMN Assayed External Control Material For Microbiology Nucleic Acid Amplification (nat) Assays
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 866.3920
Definition Assayed External Quality Control Material To Monitor The Performance Of Microbiology Nucleic Acid Assays For In Vitro Diagnostic Use.
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Microbiology devices follow this clearance model.

Regulatory Consultant

MDC Associates, Inc.
Michael Smith

The regulatory consultant manages the 510(k) submission process on behalf of the applicant - coordinating technical documentation, predicate strategy and FDA communications. Identifying the consultant behind a submission is a key signal for competitive regulatory intelligence.

Regulatory Peers - PMN Assayed External Control Material For Microbiology Nucleic Acid Amplification (nat) Assays

All 25
Devices cleared under the same product code (PMN) and FDA review panel - the closest regulatory comparables to K201403.
SPOTFIRE® RSP Pos & Neg Controls, SPOTFIRE® RSP Positive Control, SPOTFIRE® RSP Negative Control
K230868 · Maine Molecular Quality Controls, Inc. · Apr 2023
SPOTFIRE RSP Positive Control, SPOTFIRE RSP Negative Control
K221253 · Maine Molecular Quality Controls, Inc. · Feb 2023
BioFire JI Control Panel M420
K203680 · Maine Molecular Quality Controls, Inc. · Jul 2022
MDx-Chex for BCID2
K212576 · Streck, Inc. · Jan 2022
BioFire RP2.1/RP2.1plus Control Panel M441
K202196 · Maine Molecular Quality Controls, Inc. · Jun 2021
FilmArray Global Fever Panel External Control Kit
K202382 · Biofire Defense, LLC · Nov 2020